- Stem cell research passed both the House and Senate earlier this year. Maybe now the re-introduced measure can survive a veto.
- There is talk about stricter oversight of Plan D, specifically concerning costs.
- Research funding is always important, especially addressing NIH re-authorization passed by the House but not the Senate.
- A bill has been introduced that will allow the FDA to allow low-cost generics for drugs produced from living organisms.
Friday, November 10, 2006
The Election Is Over -- What Now?
Some of the new representatives will be in their home districts until the 110th Congress is seated. Take advantage of this time to inform them about issues important to the MS community. Here are some issues that should interest them: